Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 112, Issue 6, 2005, Pages 820-826

  Van Den Akker Van Marle, M E ^a   Rijnders, M E B ^a   Van Dommelen, P ^a   Fekkes, M ^a   Van Wouwe, J P ^a   Amelink Verburg, M P ^a   Verkerk, P H ^a  

^a TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIUM DETECTION; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; FEMALE; HEALTH CARE COST; HEALTH SURVEY; HUMAN; MASS SCREENING; NETHERLANDS; NEWBORN; OBSTETRIC CARE; PATIENT CARE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RISK ASSESSMENT; RISK FACTOR; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

ANTIBIOTIC PROPHYLAXIS; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 20744440318     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2005.00555.x     Document Type: Article

References (30)

1. Lin FY, Brenner RA, Johnson YR, et al. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. Am J Obstet Gynecol 2001; 184(6):1204-1210.
2. Benitz WE, Gould JB, Druzin ML. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics 1999;103(6):e77.
3. Bramer S, van Wijk FH, Mol BW, Adriaanse AH. Risk indicators for neonatal early-onset GBS-related disease. A case-control study. J Perinatol Med 1997;25(6):469-475.
4. Schuchat A, Deaver-Robinson K, Plikaytis BD, Zangwill KM, Mohle-Boetani J, Wenger JD. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. The Active Surveillance Study Group. Pediatr Infect Dis J 1994;13(7):623-629.
5. Centers for Disease Control and Prevention. Prevention of Perinatal group B Streptococcal disease. MMWR 2002;51:1-22.
6. Schrag SJ, Zell ER, Lynfield R, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002;347(4):233-239.
7. Dutch Organisation of Obstetrics and Gynaecology. Prevention of Perinatal Group B Streptococcal Disease. Gynaecology Guideline 12. Utrecht: NVOG, 1998.
8. Bergeron MG, Ke D, Menard C, et al. Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med 2000; 343(3):175-179.
9. Offerhaus PM, Anthony S, Oudshoorn CGM, Pal-de Bruin KVD, Buitendijk SE. Home Deliveries in the Netherlands. Final report: 1995-2000. PG/JGD 2001.235 ed. Leiden: TNO Prevention and Health, 2002.
10. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
11. Benitz WE, Gould JB, Druzin ML. Antimicrobial prevention of early-onset group B streptococcal sepsis: estimates of risk reduction based on a critical literature review. Pediatrics 1999;103(6):e78.
12. Broek PJVD. Update Report Urinary Tract Infections. Utrecht: The Dutch Institute for Healthcare Improvement CBO/MWR, 1999.
13. Munoz P, Coque T, Rodriguez CM, Bernaldo de Quiros JC, Moreno S, Bouza E. Group B streptococcus: a cause of urinary tract infection in nonpregnant adults. Clin Infect Dis 1992;14(2):492-496.
14. The Netherlands Perinatal Registry. Dutch Obstetrics Registration. Bilthoven: The Netherlands Perinatal Registry, 2003.
15. Trijbels-Smeulders M, Gerards LJ, PC M, et al. Epidemiology of neonatal group B streptococcal disease in The Netherlands 1997-98. Paediatr Perinat Epidemiol 2002;16(4):334-341.
16. Mohle-Boetani JC, Lieu TA, Ray GT, Escobar G. Preventing neonatal group B streptococcal disease: cost-effectiveness in a health maintenance organization and the impact of delayed hospital discharge for newborns who received intrapartum antibiotics. Pediatrics 1999; 103(4 Pt 1):703-710.
17. Haberland CA, Benitz WE, Sanders GD, et al. Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction. Pediatrics 2002;110(3):471-480.
18. Romero R, Athayde N, Maymon E, Pacora P, Bhado-Singh R. Premature rupture of membranes. In: Reece A, Hobbins J, editors. Medicine of the Fetus and Mother. Philadelphia: Lippincott-Raven, 2004: 1581-1625.
19. Shubert PJ, Diss E, Iams JD. Etiology of preterm premature rupture of membranes. Obstet Gynecol Clin North Am 1992;19(2):251-263.
20. Luck S, Torny M, d'Agapeyeff K, et al. Estimated early-onset group B streptococcal neonatal disease. Lancet 2003;361(9373):1953-1954.
21. Bonsel GJ, Gemke RJBJ. Health Utility Index-Dutch Version. Amsterdam: AMC, Department of Clinical Epidemiology and Biostatistics, 1996.
22. Feeny D, Furlong W, Boyle M, Torrance GW. TI-Multi-attribute health status classification systems. Health Utilities Index. Pharmacoeconomics 1995;7(6):490-502 (June).
23. Torrance GW, Furlong W, Feeny D, Boyle M. TI-Multi-attribute preference functions. Health Utilities Index. Pharmacoeconomics 1995: 7(6):503-520 (June).
24. National Health Tariffs Authority C. National Health Tariffs. Utrecht: CTG, 2003.
25. Rouse DJ, Goldenberg RL, Cliver SP, Cutter GR, Mennemeyer ST, Fargason CAJ. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision, analysis. Obstet Gynecol 1994; 83(4):483-494.
26. Oostenbrink JB, Koopmanschap MA, Rutten FFH. Handbook for Costing Research. Methods and Guideline Prices for Economic Evaluations in Health. Amstelveen: Health Care Insurance Board, 2000.
27. Institute for Rehabilitation Research. Request for Costs of Aids. Hoensbroek: Institute for Rehabilitation Research, 2003.
28. Dutch Ministry of Education CaS. Primary Education in Numbers. Zoetermeer. Dutch Ministry of Education, Culture and Science. 2002 [In Dutch].
29. Stan CM, Boulvain M, Bovier PA, Auckenthaler R, Berner M, Irion O. Choosing a strategy to prevent neonatal early-onset group B streptococcal sepsis: economic evaluation. Br J Obstet Gynaecol 2001; 108(8):840-847.
30. Riteco JA, de Heij LJM, van Luijn JCF, Wolff I. Guidelines for Pharmaco-economic Research. Amstelveen: National Health Insurance Board, 1999.